Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti Angiogenesis”

Showing 12 of 0 results

Not applicableUnknownNCT00518557
What this trial is testing

Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis

Who this might be right for
Hepatocellular Carcinoma
Southeast University, China 60
Early research (Phase 1)Study completedNCT00072111
What this trial is testing

Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Post-approval studies (Phase 4)Study completedNCT02497118
What this trial is testing

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Study completedNCT00117013
What this trial is testing

A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 16
Not applicableStudy completedNCT04296253
What this trial is testing

Biomarkers and SNP-polymorphisms in Post-infarction Cardiac Remodeling

Who this might be right for
Myocardial Infarction
Tomsk National Research Medical Center of the Russian Academy of Sciences 200
Not applicableEnded earlyNCT01336231
What this trial is testing

Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Cancer
Centre Francois Baclesse 82
Testing effectiveness (Phase 2)Study completedNCT00942877
What this trial is testing

Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma

Who this might be right for
Sarcoma, Alveolar Soft Part
National Cancer Institute (NCI) 53
Not applicableStudy completedNCT05208931
What this trial is testing

Development of an Optimal Algorithm for the Management of Patients With Retinal Pigment Epithelium Detachment in Neovascular Age-related Macular Degeneration Using Artificial Intelligence

Who this might be right for
Neovascular Age-related Macular Degeneration
The S.N. Fyodorov Eye Microsurgery State Institution 300
Testing effectiveness (Phase 2)UnknownNCT00684970
What this trial is testing

Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (CRPC)
Tiltan Pharma Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT00094094
What this trial is testing

Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung NeoplasmsCarcinoma, Non-small Cell Lung
Pfizer 32
Not applicableStudy completedNCT01978977
What this trial is testing

Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy In Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Hellenic Oncology Research Group 400
Testing effectiveness (Phase 2)Ended earlyNCT00131651
What this trial is testing

ATN-161 in Advanced Renal Cell Cancer

Who this might be right for
Carcinoma, Renal Cell
Attenuon 36

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation